About Alion Pharmaceuticals

About company

Alion's current focus is on developing a pipeline of small molecules with high potential of being successful in Alzheimer's disease and potentially other Central Nervous System diseases.At the same time, they are developing a powerful new approach to drug development through their One protein target, one modulator, many therapeutic applications. They are also developing a combinatoric approach to develop new therapeutics from previously approved drugs. Since the inception of the company, Alion has clearly demonstrated the "proof of concept" for their approach and programs. In planning Alion's progress, great emphasis has been placed on the mitigation of failure by maintaining several programs in the development of CNS disease therapeutics. For more information regarding our approaches to drug discovery and development, please contact us at info@alionpharma.com